Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study

Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study

Abstract Background During venovenous extracorporeal membrane oxygenation (vvECMO), direct thrombin inhibitors are considered by some potentially advantageous over unfractionated heparin (UFH). We tested the hypothesis that Argatroban is non-inferior to UFH regarding thrombosis and bleeding during v...

Full description

Bibliographic Details
Main Authors: Christoph Fisser, Maren Winkler, Maximilian V. Malfertheiner, Alois Philipp, Maik Foltan, Dirk Lunz, Florian Zeman, Lars S. Maier, Matthias Lubnow, Thomas Müller
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Critical Care
Subjects:
ECMO
Anticoagulation
Argatroban
Heparin
Thrombosis
Bleeding
Online Access:https://doi.org/10.1186/s13054-021-03581-x

Internet

https://doi.org/10.1186/s13054-021-03581-x

Similar Items